FemHealth Focus
Anixa Biosciences Advances Phase 1 Trial of FSHR-Targeted CAR-T Therapy for Recurrent Ovarian Cancer
Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer, announced that the second patient in th...
August 19, 2025 | News
SOPHiA GENETICS and AstraZeneca Expand AI Collaboration to Advance Personalised Breast Cancer Care
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine,announced an expansion of its...
August 06, 2025 | News
Bracco Imaging’s SonoVue® Gains NMPA Approval for HyCoSy Use in Infertility Diagnosis in China
Bracco Imaging, a global leader in diagnostic imaging,announced that its ultrasound contrast agent SonoVue® has been approved by the China's&...
August 06, 2025 | News
Alphamab Oncology’s HER2-Targeting ADC JSKN003 Secures FDA Orphan Drug Designation for Gastric and GEJ Cancers
Alphamab Oncology announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation (ODD) by the U.S. Foo...
July 29, 2025 | News
Bayer’s Elinzanetant Faces FDA Review Extension, No Concerns Raised on Approvals
Bayer announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinza...
July 28, 2025 | News
The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
The region’s women’s digital health market is projected to grow to $ 2,295.7 million by 2030, according to Grand View Research. This surge refl...
July 17, 2025 | News
DKSH Partners with Bayer to Expand Access to Cardiovascular and Women’s Health Products Across Southeast Asia
DKSH has signed a strategic business partnership with life science company Bayer, to provide comprehensive services for a portion of t...
July 10, 2025 | News
Celltrion Launches STOBOCLO® and OSENVELT® Biosimilars in the U.S. for Comprehensive Bone Health and Oncology Care
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA® (denosumab) and X...
July 08, 2025 | News
Koning Health Debuts in UAE with Instalalation of Region’s First No-Compression 3D Breast Imaging System
Koning Health is proud to announce the installation of the Koning Vera at the Family Health Promotion Center in Sharjah, United Arab Emirat...
June 24, 2025 | News
Clover Biopharma Begins Phase I Trial of Respiratory Combination Vaccines in Older Adults
Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovat...
June 18, 2025 | News
Akesis Biologics Launches MastGut: A First-in-Class Probiotic Supplement Targeting Gut Inflammation and Colorectal Health
Akesis Biologics, a biotechnology spin-off from the National University of Singapore (NUS), has officially launched its flagship gut health product, M...
June 10, 2025 | News
Akeso’s Cadonilimab Secures NMPA Approval for First-Line Treatment of Cervical Cancer
Akeso, Inc. is pleased to announce that the National Medical Products Administration (NMPA) has approved the company's first- in-class PD-1/CTLA-4 bispecif...
June 05, 2025 | News
Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms
Astellas Singapore has announced that the Health Sciences Authority (HSA) of Singapore has approved VEOZA™ (fezolinetant) 45 mg for the treatment of ...
June 04, 2025 | News
Lunit Expands U.S. Footprint with AI-Powered Breast Cancer Screening at Over 200 Sites
Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imagi...
May 20, 2025 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
